Published in
American Association for the Advancement of Science, Science Translational Medicine, 507(11), 2019
DOI: 10.1126/scitranslmed.aav6221
Links
Tools
Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease
Journal article published in 2019 by
Michael Ewers,
John Q. Trojanowski,
Michael W. Weiner,
Nicolai Franzmeier,
Marc Suárez-Calvet 
,
Estrella Morenas-Rodriguez,
Miguel Angel Araque Caballero,
Caballero Maa,
Gernot Kleinberger,
Laura Piccio ,
Carlos Cruchaga,
Yuetiva Deming,
Martin Dichgans,
Leslie M. Shaw,
Christian Haass
and other authors.
,
Estrella Morenas-Rodriguez,
Miguel Angel Araque Caballero,
Caballero Maa,
Gernot Kleinberger,
Laura Piccio ,
Carlos Cruchaga,
Yuetiva Deming,
Martin Dichgans,
Leslie M. Shaw,
Christian Haass
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Higher CSF sTREM2 concentrations are associated with slower rates of cognitive decline in subjects with Alzheimer’s disease.